newsfilter
← Latest News
GlobeNewswire·

Rubius Therapeutics Announces Process to Explore Strategic Alternatives and Leadership Changes

Dannielle Appelhans to Become President and Chief Executive Officer Pablo J. Cagnoni, M.D., Appointed Chair of the Board of Directors CAMBRIDGE, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc.